Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial

Read my latest #research on #COVID-19 has just been published with @SpringerNature in @BMCInfectiousdiseases. Read here:https://t.co/LNBCTTJjQ3

Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial https://t.co/HXZjrsnKRi

Nuova pubblicazione @BioMedCentral nell’ambito dello studio PLACO #COVID #plasma @cittasalute_to 👉 https://t.co/XWlUxneljZ

Convalescent or standard plasma versus standard of care in the [ https://t.co/8mMYU2faKi ] Given the lack of evidence for effective treatment of #Covid19 during the first and estimated in terms of RR with a MantelHaenszel Chi-square test. https://t.co/aAyU